Acumen Pharmaceuticals, Inc.

11/27/2025

This season reminds us of what truly matters. As we recognize National Family Caregivers Month and gather in the spirit of Thanksgiving, we honor the families, caregivers, advocates, and researchers who continue to move this field forward.

We’re grateful for the compassion and partnership that carry this community toward a brighter future.

11/26/2025

We're proud to share that Acumen is a Silver Sponsor of the CTAD Conference this year in San Diego. We look forward to connecting with those attending !

Click here for details on Acumen's presentation details: https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-present-recruitment-strategies-phase-2

11/24/2025

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredible team members and the amazing work they do!

November's 'Ask Acumen' featured team member is Kristin Aldridge, Manager, PMO Project Management.

🔗 Click the link below to get a behind-the-scenes look at Kristin's journey, passions, and outstanding contributions to our mission: https://acumenpharm.com/ask-acumen/

11/20/2025

Giving back to the community is one of the many ways our team stays connected to what matters most.

Recently, Acumen team members Julie and Kris volunteered their time with Joy's House an organization that provides adult and caregiver services that are truly dear to our hearts.

During their visit, they also had a special guest appearance from Paws and Think and one of their amazing therapy dogs Ozzie, reminding us all how powerful comfort, connection, and care can be.

We’re proud of our colleagues for sharing their time and hearts in support of Joy’s House and the community it serves. 💜

11/18/2025

We're excited to be attending this year’s CTAD Conference! We will have two poster presentations, one on recruitment strategies for our ALTITUDE-AD study of sabirnetug, and another on nonclinical Enhanced Brain Delivery (EBD™) – focusing on fusing transferrin receptor binders to sabirnetug to facilitate its transport through the blood-brain barrier.

For more information about our presentations visit: https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-present-recruitment-strategies-phase-2

11/17/2025

We are pleased to announce the first participant dosed in the open-label extension of our Phase 2 ALTITUDE-AD trial for sabirnetug.

This extension gives participants who completed the 18-month placebo-controlled portion the chance to receive sabirnetug for an additional 52 weeks, helping gather critical long-term safety and efficacy data. This study will help us gather additional insights that will support our continued development of this potentially differentiated therapeutic approach.

Learn more: https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-announces-first-participant-dosed-phase-2

11/13/2025

👣Acumen team members have been showing up across the country for the Alzheimer's Association "Walk to End Alzheimer's" events. Liean and Julie joined the Indianapolis walk in October; and this past weekend Mahsan walked in Oahu, HI. Kudos to all who participated along with their families and friends for their commitment to the cause!

11/12/2025

Today we announced our third quarter financial results and business highlights.

🔗Click link to read the release: https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-reports-third-quarter-2025-financial

11/10/2025

Acumen is pleased to announce the addition of George Golumbeski, Ph.D., to our Board of Directors. Learn more about Dr. Golumbeski and the experience he brings to Acumen in the full announcement.

🔗 To read more, visit the link below
https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-appoints-george-golumbeski-phd-chairman

11/03/2025

November is National Alzheimer’s Disease Awareness Month and National Family Caregivers Month — a time to honor the strength, love, and resilience of those navigating this journey together.

Our team had the privilege of meeting Kerry Dennis this summer at an in-person company meeting, where she shared her story of living with early-stage Alzheimer’s. This new piece from the Alzheimer's Association highlights Kerry and her husband Rob, whose compassion and partnership remind us what caregiving truly looks like in action. Their story is inspiring, heartfelt, and a meaningful reflection for this month of awareness.

🔗 Read Kerry and Rob’s story here: https://www.alz.org/blog/2025/caregiving-is-love-in-action-kerry-and-rob-s-story

For Kerry and Rob, caregiving is an act of love, strength and grace. See how they are facing early-stage Alzheimer's together.

10/27/2025

👣This past weekend Acumen team members hit the pavement in Boston, MA; Charleston, SC; and Charlottesville, VA for the Alzheimer's Association 'Walk to End Alzheimer's'. Kudos to Laura, Jing, Amy, Dan, Kimber, and Rebecca, along with their families and friends for their commitment to the cause!

10/20/2025

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredible team members and the amazing work they do!

October's 'Ask Acumen' featured team member is Todd Feaster, PsyD, Senior Clinical Research Scientist.

🔗 Click the link below to get a behind-the-scenes look at Todd's journey, passions, and outstanding contributions to our mission: https://acumenpharm.com/ask-acumen/